Milwaukee, June 26, 2018 – After muscular dystrophy took the life of his childhood friend more than 20 years ago, Dr. Michael Lawlor swore never to give up on finding new ways to treat these types of devastating disease.
Dr. Michael Lawlor, MD, PhD, associate professor of pathology at the Medical College of Wisconsin (MCW), and his lab at MCW have been involved in a worldwide collaboration to develop hope for those suffering from neurological disorders. Over the last five years, the team has helped develop and translate a gene therapy for myotubular myopathy that has shown great clinical potential.
Today, Lawlor, MD, PhD, associate professor of pathology at MCW, is involved in a worldwide collaboration studying the use of gene therapies to treat neurological disorders. A dedicated researcher and clinician, Dr. Lawlor was honored at the annual Imagine More Dinner in Milwaukee on Thursday, June 14.
Dr. Lawlor informed the hundreds of guests in attendance about the effects of myotubular myopathy, and the strain it puts on families. Patients with this severe rare disease often suffer profound muscle weakness, respiratory failure and early death, and there are currently no approved treatment options.
Over the past five years, however, Dr. Lawlor’s team has helped develop and translate a gene therapy showing great clinical potential. The results from the research were so promising that the therapy was approved for clinical trials on human patients beginning in September 2017.
Dr. Lawlor’s discovery has sparked a renewed sense of hope for families who previously had none.
Hosted each year by the Neuroscience Research Center at the Medical College of Wisconsin, the Imagine More Dinner supports research for the cause and cure of devastating neurological diseases. This year’s event raised a record amount of more than $250,000.
Latest press releases, stories and resources.